{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:03:04Z","timestamp":1794049384031,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijid.2023.11.022","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T21:47:57Z","timestamp":1700689677000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effectiveness of the Euvichol\u00ae oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5371-1354","authenticated-orcid":false,"given":"Wilfredo R.","family":"Matias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yodeline","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8131-3512","authenticated-orcid":false,"given":"Gertrude","family":"Cene Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenia","family":"Vissieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Ternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien M.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly F.","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-9230","authenticated-orcid":false,"given":"Louise C.","family":"Ivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.11.022_bib0001","unstructured":"World Health Organization. Cholera - global situation, https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON426; 2022 [accessed 04 January 2023]."},{"key":"10.1016\/j.ijid.2023.11.022_bib0002","unstructured":"World Health Organization. Cholera vaccines: WHO position paper, https:\/\/www.who.int\/publications-detail-redirect\/who-wer9234-477-500; 2017 [accessed 25 March 2023]."},{"key":"10.1016\/j.ijid.2023.11.022_bib0003","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Oral Cholera Vaccine Working Group of the Global Task Force on Cholera Control. Global oral cholera vaccine use, 2013\u20132018","volume":"38","author":"Pezzoli","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2023.11.022_bib0004","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global Public Private Partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2023.11.022_bib0005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(22)02116-X","article-title":"Cholera vaccines rationed amid global shortage","volume":"400","author":"Devi","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2023.11.022_bib0006","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.11.022_bib0007","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3346\/jkms.2014.29.4.494","article-title":"Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea","volume":"29","author":"Baik","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijid.2023.11.022_bib0008","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2023.11.022_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.15585\/mmwr.mm7202a1","article-title":"Cholera outbreak \u2014 Haiti, September 2022\u2013January 2023","volume":"72","author":"Vega Ocasio","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2023.11.022_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007967","article-title":"High cholera vaccination coverage following emergency campaign in Haiti: results from a cluster survey in three rural Communes in the South Department, 2017","volume":"14","author":"Sharp","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2023.11.022_bib0011","series-title":"Use and Perspectives of the oral cholera vaccine (OCV) as a component of the Cholera Response","author":"Pierre","year":"2018"},{"key":"10.1016\/j.ijid.2023.11.022_bib0012","doi-asserted-by":"crossref","first-page":"e1028","DOI":"10.1016\/S2214-109X(18)30284-5","article-title":"Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study","volume":"6","author":"Franke","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2023.11.022_bib0013","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1016\/j.vaccine.2019.09.018","article-title":"Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014","volume":"37","author":"Burnett","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2023.11.022_bib0014","series-title":"The treatment of diarrhoea: a manual for physicians and other senior health workers","year":"2005"},{"key":"10.1016\/j.ijid.2023.11.022_bib0015","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1016\/j.vaccine.2019.05.044","article-title":"Effectiveness of oral cholera vaccine in preventing cholera among fishermen in Lake Chilwa, Malawi: a case-control study","volume":"37","author":"Grandesso","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2023.11.022_bib0016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJMc1711583","article-title":"Single-dose cholera vaccine in response to an outbreak in Zambia","volume":"378","author":"Ferreras","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2023.11.022_bib0017","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study","volume":"4","author":"Azman","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2023.11.022_bib0018","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2023.11.022_bib0019","doi-asserted-by":"crossref","first-page":"ofad301","DOI":"10.1093\/ofid\/ofad301","article-title":"Poor sensitivity of stool culture compared to polymerase chain reaction in surveillance for V. cholerae in Haiti, 2018\u20132019","volume":"10","author":"Guillaume","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2023.11.022_bib0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/oxfordjournals.aje.a009196","article-title":"Study designs for evaluating different efficacy and effectiveness aspects of vaccines","volume":"146","author":"Halloran","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2023.11.022_bib0021","unstructured":"Therneau T. A package for survival analysis in R. R Statistical Software, https:\/\/CRAN.R-project.org\/package=survival; 2023 [accessed 21 April 2023]."},{"key":"10.1016\/j.ijid.2023.11.022_bib0022","doi-asserted-by":"crossref","first-page":"e00412","DOI":"10.1128\/JCM.00412-20","article-title":"Gold standard cholera diagnostics are tarnished by lytic bacteriophage and antibiotics","volume":"58","author":"Nelson","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2023.11.022_bib0023","doi-asserted-by":"crossref","first-page":"e37360","DOI":"10.1371\/journal.pone.0037360","article-title":"Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard","volume":"7","author":"Page","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2023.11.022_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066945","article-title":"Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017\/2018 outbreak: a matched case-control study in Lusaka, Zambia","volume":"12","author":"Sialubanje","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2023.11.022_bib0025","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S2214-109X(14)70368-7","article-title":"Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis","volume":"3","author":"Ivers","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2023.11.022_bib0026","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S1473-3099(22)00752-6","article-title":"Addressing the shortage of cholera vaccines","volume":"22","author":"Burki","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.11.022_bib0027","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1017\/S095026882000062X","article-title":"Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia","volume":"148","author":"Ferreras","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2023.11.022_bib0028","unstructured":"Malambaka EB, Bugeme PM, Hutchins C, et\u00a0al. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of Congo: a matched case-control study. medRxiv. 07 November 2023. https:\/\/www.medrxiv.org\/content\/10.1101\/2023. 08.07.23293369; [accessed 25 September 2023]."},{"key":"10.1016\/j.ijid.2023.11.022_bib0029","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.13-0183","article-title":"Use of oral cholera vaccine in Haiti: a rural demonstration project","volume":"89","author":"Ivers","year":"2013","journal-title":"Am J Trop Med Hyg"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223007841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223007841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:25:39Z","timestamp":1778592339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223007841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"alternative-id":["S1201971223007841"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.11.022","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the Euvichol\u00ae oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}